The Treatment

Every other device works on the skin. Endolift® works inside it.

Endolift® delivers 1470nm laser energy directly beneath the skin, targeting fat, triggering collagen, and tightening tissue from the inside out. In one session. Under local anaesthetic. In your clinic.
Request Clinical Pack

Results that speak for themselves

❌
External Devices

RF, HIFU, and ultrasound must penetrate through the epidermis before reaching target tissue. Energy is lost at every layer. The physics set a ceiling on results and most patients have already hit it.

❌
Injectables
Fillers compensate. Toxins relax. Neither addresses the structural cause of laxity – subdermal fat accumulation and collagen loss deep in the reticular dermis. There is a limit to how long you can compensate before the result looks unnatural.
❌
Surgery
While surgery remains the gold standard for severe cases, it requires a theatre, general anaesthetic, and weeks of recovery and carries the risks associated with all of the above. For the growing cohort of patients who aren’t ready or simply refuse, surgery leaves a gap.

Endolift® was engineered to close that gap.

The science is the story.

Four things happen simultaneously beneath the skin. No other procedure delivers all four in a single session.
01
Selective Adipolysis
The 1470nm wavelength is preferentially absorbed by adipocyte membranes, inducing targeted disruption and permanent volume reduction of the fat deposit. The energy is selective – surrounding tissue is spared.
02
Fibroblast Activation

The controlled thermal zone activates resident fibroblasts in the reticular dermis, triggering a cascade of new collagen and elastin synthesis, the structural proteins responsible for skin firmness that diminish with age.

03
Immediate Tissue Contraction

Existing collagen fibres undergo immediate thermal contraction during the procedure. Visible tightening begins before the patient leaves the clinic.

04
Progressive Remodelling Cascade
Neo-collagenesis continues for 3–6 months post-procedure. Results don’t peak immediately; they improve progressively and naturally, exactly as genuine biological remodelling does. Patients get better over time, not worse.
Request Clinical Pack

Clinical indications of Endolift®

Jawline & Jaw Laxity
Learn More
Neck & Submental Fat
Learn More
Malar Oedema
Learn More
Upper Arms
Learn More
Abdomen & Flanks
Learn More
Inner Thighs
Learn More
Knees
Learn More
Gluteal Region
Learn More
Acne Scars
Learn More
Cellulite
Learn More

Who is right for Endolift®? And who isn't?

Precise patient selection is what separates good results from exceptional ones.

Suitable Candidates

  • Mild to moderate skin laxity on face, neck, or body
  • Localised fat resistant to conservative treatment
  • Combined fat + laxity, classic under-served presentation
  • Patients declining surgery or at surgical threshold
  • Patients who have plateaued on injectables or devices
  • Post-weight-loss residual pockets with laxity
  • Atrophic acne scarring - rolling, boxcar, and icepick subtypes
  • Skin types I–VI - no epidermal risk from subdermal deliveryss residual pockets with laxity

Not Indicated

  • Severe ptosis requiring surgical correction
  • Active inflammatory conditions in the treatment zone
  • Large-volume fat reduction, refer to surgical liposuction
  • Active acne, must be fully resolved prior to treatment
  • Patients expecting surgical-equivalent volume correction

Not a replacement of what you do. An extention of it.

Endolift® doesn’t compete with your injectable protocols or your surgical referral pathway. It fills the structural gap between them.

Injectables

RF / HiFu / Threads

Endolift®

Surgical Liposuction

Surgical Facelift

Standalone Endolift®
For patients in the early-to-moderate window. Endolift® delivers structural change that injectables cannot and non-invasive devices won’t. It stands entirely on its own.
As a Combination Protocol
Works alongside skin boosters, resurfacing, and injectables. Many practitioners use Endolift® to address structural laxity while continuing to manage skin quality with their existing portfolio.
As a Surgical Bridge
For patients approaching surgical candidacy who aren’t ready. Endolift® delivers meaningful improvement that extends the non-surgical window, keeping patients satisfied and loyal to your clinic.

What happens? And when?

Results are progressive by design, because genuine collagen remodelling is a biological process, not an instant effect. Here is what your patients should expect.
Weeks 0 – 2
Immediate Reaction
Instant skin retraction, followed by a mild swelling and localised tenderness. Patient returns home same day. No theatre recovery.
Weeks 3-4

Initial Progress

Swelling fully resolves. Initial contour changes begin to emerge. Patients typically notice before their practitioner points it out.
Weeks 4-8

The Glow Phase

Visible tightening and volume reduction evident. Most patients see the result they were hoping for.
Months 3-4

Primary Peak

Collagen remodelling in full progression. The result continues to improve without any further intervention.
Months 5-6

Stabilisation

Results continue improving. Skin tightening typically lasts 12–24 months depending on age, skin quality, and indication. Fat reduction is permanent.

Trusted By Industry Leaders

“

We saw that a large number of patients were really getting significant improvements in a way that we’ve not seen any treatment being able to address this before. And that’s very rare in aesthetics.

Mr Daniel Ezra
Consultant Oculoplastic Surgeon
(152 Harley Street)
“

In our practice the Endolift® is one of the main non-surgical treatments that we’re doing. The patient satisfaction rate is above 95%. If you select your patients carefully, you can achieve amazing results.

Dr Deniz Kanliada
Facial Plastic and Reconstructive Surgeon
(Dr Deniz Kanliada Clinic)
“
Endolift® is a revolutionary, and innovative treatment, that is low-downtime and helps to improve skin tightening, while simultaneously reducing fat in selective areas of the face. It’s one of a kind treatment.
Dr Yusra Al-Mukhtar
Dental Surgeon & Facial Aesthetics Practitioner
(Dr Yusra Clinic)
“
I’m very happy with the procedure, as are my patients. It’s really changed my practice. I find it revolutionary, especially in terms of the jawline (contouring), and minimal dontime.
Dr Vincent Kent
Medical Doctor
(DrVKent Clinics)

Your Patients are Ready. Are you?

Talk to our team. See the evidence. Watch the procedure. Then decide.

Become an Endolift® Practitioner
Request Clinical Pack

Request Clinical Pack

* We DO NOT offer training to NMC, HCPC, or GPhC professionals.

Jawline & Jaw Laxity

Clinical Overview

Jowl formation results from the progressive weakening of mandibular retaining ligaments combined with subdermal fat redistribution and dermal collagen loss. The result is a loss of the sharp mandibular border and the characteristic descent of soft tissue below the jawline. Injectables can temporarily camouflage but cannot address the underlying adipose component or stimulate meaningful structural collagen remodelling at this depth.

Why Endolift® works here?

The 1470nm fibre is placed subdermally along the mandibular border, delivering targeted lipolytic energy to the jowl fat pad while inducing a controlled thermal injury response in the reticular dermis. This triggers fibroblast activation and neocollagenesis precisely where ligamentous support has been lost – something no external device can replicate.

Ideal Candidate Profile

  • Mild to moderate jowl laxity with visible mandibular border loss
  • Localised submental or pre-jowl fat deposit
  • Patient declining or not yet suitable for surgical rhytidectomy
  • Good skin elasticity with realistic expectations for progressive improvement
  • Not indicated in severe ptosis requiring surgical correction

Expected Outcomes

  • Restored mandibular definition and jawline sharpness
  • Reduction of jowl volume and submental fat
  • Progressive dermal tightening over 3–6 months
  • Natural-looking result without the tell-tale signs of surgical intervention
Neck & Submental Fat

Clinical Overview

Submental fat accumulation, commonly referred to as a ‘double chin’, is one of the most common aesthetic concerns across all age groups and body types. It is frequently resistant to diet and exercise due to its genetic and hormonal determinants. External devices address surface skin only; without targeting the subdermal fat pad directly, results remain superficial and temporary.

Why Endolift® works here?

The submental region is one of the most technically accessible zones for Endolift® fibre placement. The 1470nm wavelength achieves direct adipolysis of the submental fat pad while simultaneously tightening the overlying platysmal skin, delivering the dual result that patients who’ve tried Kybella, CoolSculpting, or RF tightening alone have been unable to achieve.

Ideal Candidate Profile

  • Localised submental fat with or without skin laxity
  • Patient seeking non-surgical alternative to liposuction or neck lift
  • Early to moderate platysmal banding without surgical indication
  • Suitable across a wide age range (28–65)
  • Not indicated where significant platysmal diastasis requires surgical repair

Expected Outcomes

  • Visible reduction of submental fat volume
  • Improved cervicomental angle definition
  • Skin tightening of the anterior neck
  • Single session with no surgical recovery
Malar Oedema

Clinical Overview

Malar oedema – fluid and fat accumulation in the malar and infraorbital region – presents as persistent puffiness beneath the eyes that does not resolve with sleep or lifestyle modification. It is notoriously difficult to treat. Filler in this zone frequently exacerbates the problem by adding volume. Surgical approaches carry significant risk given proximity to the infraorbital nerve and orbital septum.

Why Endolift® works here?

Endolift® is one of the very few non-surgical modalities capable of addressing malar oedema directly. The fine-calibre fibre allows precise subdermal placement in this technically demanding zone, delivering controlled energy to reduce localised fat and stimulate tissue contraction without the risks associated with surgical intervention near the orbital rim.

Ideal Candidate Profile

  • Persistent malar festoons or malar oedema unresponsive to conservative treatment
  • Patient with history of filler-worsened infraorbital fullness
  • Patient declining blepharoplasty or midface surgery
  • Not indicated in active inflammatory conditions of the periorbital area

Expected Outcomes

  • Reduction in malar puffiness and festoon volume
  • Improved infraorbital contour
  • More rested, defined midface appearance
  • Progressive improvement over several months
Upper Arms

Clinical Overview

Upper arm laxity — commonly referred to as ‘bat wings’ or ‘bingo wings’ — involves both excess subdermal fat and skin laxity along the posterior and medial triceps regions. It is one of the body areas patients are most self-conscious about and one of the hardest to treat non-surgically. Fat freezing reduces volume but leaves loose skin. RF tightening addresses surface laxity but cannot reduce the underlying fat pad.

Why Endolift® works here?

The 1470nm fibre addresses both problems simultaneously — lipolysis of the posterior arm fat pad combined with dermal tightening from the inside. This dual mechanism is uniquely suited to the upper arm where the combination of excess fat and lax skin requires both to be addressed in the same procedure to produce a satisfying result.

Ideal Candidate Profile

  • Mild to moderate posterior arm fat with overlying skin laxity
  • Patient who has tried external body contouring without satisfactory result
  • Patient declining brachioplasty due to visible scarring concern
  • Good overall health and stable body weight
  • Not indicated in severe arm ptosis requiring surgical skin excision

Expected Outcomes

  • Reduction of posterior arm fat volume
  • Improved skin firmness and contour along the triceps
  • Sleeker arm profile without surgical scarring
  • Single session result continuing to improve over months

Abdomen & Flanks

Clinical Overview

Abdominal and flank fat deposits represent the most common body contouring concern globally. While surgical liposuction remains the gold standard for large volume reduction, a significant patient cohort presents with localised, modest deposits — post-pregnancy, post-weight loss, or age-related — that are disproportionate to their overall body composition and insufficiently addressed by non-invasive alternatives.

Why Endolift® works here?

Endolift® occupies the clinical gap between non-invasive devices that underdeliver and surgical liposuction that patients find too aggressive. The 1470nm fibre delivers precise lipolysis to targeted abdominal and flank fat compartments while simultaneously tightening overlying skin — making it particularly valuable in post-weight-loss patients where skin laxity accompanies fat reduction.

Ideal Candidate Profile

  • Localised abdominal or flank fat not suitable for or responsive to non-invasive treatment
  • Post-pregnancy patients with diastasis not requiring surgical repair
  • Post-weight-loss patients with residual pockets and mild skin laxity
  • Stable body weight with realistic expectations
  • Not indicated for large-volume fat reduction — refer to surgical liposuction

Expected Outcomes

  • Visible reduction of targeted fat deposits
  • Improved skin firmness over the treated zone
  • Smoother abdominal contour without surgical recovery
  • Results continuing to develop over several months
Inner Thighs

Clinical Overview

Inner thigh laxity and localised fat accumulation is a notoriously undertreated indication in aesthetic medicine. The anatomy of the medial thigh — thin skin, proximity to lymphatic structures, and the dynamic stresses of ambulation — makes it poorly suited to many energy-based devices. Patients frequently report dissatisfaction with non-invasive options and are often not suitable or willing candidates for medial thigh lift surgery.

Why Endolift® works here?

The precision of Endolift® fibre placement is particularly advantageous in the medial thigh, where anatomical caution is required. Subdermal delivery of 1470nm energy reduces the localised fat pad while tightening the characteristically thin medial thigh skin — without the lymphatic disruption risk of more aggressive surgical approaches.

Ideal Candidate Profile

  • Localised medial thigh fat with or without skin laxity
  • Patient with skin quality unsuitable for external RF or laser
  • Patient declining medial thigh lift due to scar placement concerns
  • Active patients for whom thigh chafing or contour is a functional as well as aesthetic concern
  • Not indicated in severe medial thigh ptosis requiring surgical skin excision

Expected Outcomes

  • Reduction of inner thigh fat volume
  • Improved medial thigh skin firmness
  • Reduced thigh gap irregularity
  • Progressive tightening over several months
Knees

Clinical Overview

Periarticular knee fat and skin laxity — the medial and suprapatellar fat pads combined with loss of skin elasticity — is one of the most age-revealing body areas and one of the least addressed in aesthetic practice. Very few devices are suitable for the knee anatomy, and surgical options carry disproportionate risk and recovery relative to the modest correction most patients seek.

Why Endolift® works here?

The knee represents an ideal Endolift® indication precisely because the alternatives are so limited. Fibre placement in the medial knee fat pad and suprapatellar region allows targeted lipolysis and dermal tightening in an area where external devices cannot penetrate to meaningful depth and surgery is rarely proportionate.

Ideal Candidate Profile

  • Medial knee fat pad prominence or suprapatellar laxity
  • Patient with age-related periarticular skin loosening
  • Patient who has noted knee appearance as a specific aesthetic concern
  • No active joint pathology in the treated area
  • Not indicated in patients with active inflammatory arthritis or recent knee surg

Expected Outcomes

  • Reduction of medial and suprapatellar fat prominence
  • Tighter, more defined periarticular skin
  • Younger-looking knee contour
  • Minimal recovery with rapid return to normal activity
Gluteal Region

Clinical Overview

Gluteal contouring — addressing subgluteal fat accumulation, banana fold prominence, and lateral hip excess — is a rapidly growing indication in aesthetic medicine driven by patient demand for body reshaping without implants or surgical fat transfer. The gluteal region combines high patient sensitivity with complex anatomy, making it an area where surgical risk must be weighed carefully and non-surgical options have historically been inadequate.

Why Endolift® works here?

Endolift® allows precise fibre placement in the subgluteal fold and lateral gluteal region, targeting localised fat deposits and tightening overlying skin to improve contour definition. Unlike surgical gluteal augmentation, there is no implant risk, no general anaesthesia, and no prolonged sitting restriction — making it accessible to a far broader patient population.

Ideal Candidate Profile

  • Subgluteal fold prominence or banana roll fat deposit
  • Lateral hip or saddlebag localised fat
  • Patient seeking gluteal definition without augmentation or surgical fat transfer
  • Stable body weight with realistic expectations for contouring rather than augmentation
  • Not indicated where gluteal augmentation or significant volume addition is the patient goal

Expected Outcomes

  • Reduction of subgluteal and lateral hip fat
  • Improved gluteal contour and lift appearance
  • Smoother banana fold transition
  • Single session with progressive improvement
Acne Scars

Clinical Overview

Atrophic acne scarring — including rolling, boxcar, and icepick subtypes — results from dermal collagen destruction during the inflammatory acne process. It remains one of the most psychologically impactful aesthetic concerns and one of the most technically challenging to treat. Ablative lasers resurface from above but cannot address the subdermal fibrous tethering that causes the characteristic rolling and tethered appearance of more severe scarring.

Why Endolift® works here?

By delivering 1470nm energy subdermally, Endolift® targets the fibrous tethering bands beneath rolling and boxcar scars directly — releasing the tethering while simultaneously stimulating new collagen deposition in the dermal defect. This inside-out approach addresses the structural cause of atrophic scarring rather than treating the surface alone, offering improvement in cases where repeated resurfacing has reached a plateau.

Ideal Candidate Profile

  • Moderate to severe atrophic acne scarring, particularly rolling and boxcar subtypes
  • Patient who has reached a plateau with ablative or fractional laser resurfacing
  • Skin types III–VI where ablative laser risk is elevated
  • Active acne fully controlled prior to treatment
  • Not indicated in active inflammatory acne or keloid-forming patients

Expected Outcomes

  • Visible improvement in rolling and boxcar scar depth
  • Improved overall skin texture and dermal volume
  • Complementary to surface resurfacing when used in combination
  • Progressive collagen remodelling over 3–6 months
Cellulite

Clinical Overview

Cellulite affects an estimated 85–90% of post-pubertal women regardless of body weight and is caused by the herniation of subcutaneous fat through fibrous septae in the dermis, producing the characteristic dimpled surface appearance. It is one of the most heavily marketed aesthetic indications and simultaneously one of the most undertreated — because most devices address the surface while the structural cause lies in the fibrous septae below.

Why Endolift® works here?

Endolift® targets cellulite at its structural origin. Subdermal fibre placement allows direct delivery of 1470nm energy to the fibrous septae, inducing thermal disruption of the tethering bands combined with lipolysis of the herniated fat lobules — addressing both causative mechanisms simultaneously. This subdermal approach differentiates Endolift® from topical, RF, and acoustic wave devices that cannot reach the septae directly.

Ideal Candidate Profile

  • Grade II–III cellulite (visible at rest, moderate dimpling)
  • Patient who has tried topical or external device treatments without lasting improvement
  • Localised cellulite on thighs, buttocks, or abdomen
  • Stable body weight and realistic expectations for improvement rather than elimination
  • Grade I cellulite (only visible when skin compressed) — conservative treatment more appropriate

Expected Outcomes

  • Visible reduction in cellulite dimpling and surface irregularity
  • Improved skin texture and dermal firmness
  • Reduction of underlying fat lobule volume
  • Progressive improvement over 3–6 month

Become an Endolift® Practitioner

PLEASE, BE ADVISED THAT IF YOU ARE NOT A MEDICAL PROFESSIONAL REGISTERED WITH THE GMC OR GDC, DO NOT SUBMIT AN INQUIRY. WE ARE NOT OFFERING TRAINING TO NON-MEDICAL PERSONNEL.

TRAINING WILL BE PROVIDED FOLLOWING THE PURCHASE OF EUFOTON® LASEMAR 1500

Request Pricing & Finance Options

PLEASE, BE ADVISED THAT IF YOU ARE NOT A MEDICAL PROFESSIONAL REGISTERED WITH THE GMC OR GDC, DO NOT SUBMIT AN INQUIRY. WE ARE NOT OFFERING TRAINING TO NON-MEDICAL PERSONNEL.

TRAINING WILL BE PROVIDED FOLLOWING THE PURCHASE OF EUFOTON® LASEMAR 1500

The Endolift® procedure is a cutting-edge, medical-only non-surgical laser treatment renowned for its remarkable ability to firm and tone the skin, effectively reducing laxity by retracting excess skin. In cases where necessary, ENDOLIFT® is also employed for reducing excessive fat and reshaping the face. It is often referred to as the gold standard in non- invasive skin tightening technology.
Ideal candidates for Endolift® are individuals with mild to moderate skin laxity on the face or body. This treatment is suitable for all skin types!
Endolift® stands as a distinct technology, often hailed as the non-invasive gold standard for achieving effective and long-lasting facelifts (skin tightening). Thanks to its thin probe, it can also be effectively used for tasks like acne scar subcision and cellulite subcision, yielding exceptional results.
Endolift® boasts a unique pedigree, developed by a team of experts over two decades ago. Attempts to replicate our technology can be found in the market, but our Fibres and Lasemar1500 devices remain unmatched in terms of efficacy and quality.
During the Endolift® procedure, a remarkably thin fibre-optic laser probe is inserted under the skin without the need for incisions. The laser energy is then carefully delivered to the deeper layers of the skin, stimulating collagen production and tightening the tissues. This controlled laser energy application kickstarts the body's natural healing process, resulting in skin tightening and improved texture. Additionally, the doctor can adjust the power to deliver enough energy to destroy adipose fat cells when required, which are then naturally eliminated by the lymphatic system.
Endolift® is commonly employed to treat areas of the face and neck that exhibit signs of aging, such as sagging skin, wrinkles, and loss of elasticity. It's often used to target the jawline, cheeks, nasolabial folds (smile lines), and the neck. Furthermore, it has proven highly effective in reducing localized fat in areas like the belly, inner thighs, bingo wings, and love handles.
The procedure is virtually painless. Local anesthesia is typically administered to numb the treatment area, minimizing any discomfort. While some patients may experience mild discomfort or a sensation of warmth during the procedure, it's generally not described as painful.
Endolift® triggers the natural production of structural proteins like collagen and elastin, resulting in improved skin 'architecture.' Early signs of improvement can often be observed within 4-8 weeks, with the process continuing over time. The peak results are usually realized 9-12 months after the procedure.
Yes, ENDOLIFT® is an FDA-approved minimally invasive outpatient laser procedure used in interstitial (endo-tissutal) aesthetic medicine. The laser treatment employs the latest Eufoton® LASEmaR® 1500, certified and approved by the American FDA for laser-assisted liposuction.
One of the primary benefits of Endolift® is its minimal downtime. Patients may experience some mild swelling, redness, and bruising in the treated area, typically subsiding within a few days to a week. Most patients can resume their normal activities shortly after the procedure.
The longevity of Endolift® results can vary from person to person. However, effects generally persist for several months to a few years. Maintenance treatments may be recommended to sustain results over time.
Endolift® is a skill-based procedure, exclusively performed by qualified medical practitioners who have undergone specialized training.
Endolift® results are both immediate and long-lasting. Following the treatment, results will continue to develop over several months as additional collagen forms in the deeper layers of the skin. Typically, these results can endure for 2 to 3 years, with the option to repeat the treatment after a year if desired.

Make an Enquiry

Make an Enquiry

We will get back to you shortly

PLEASE, BE ADVISED THAT IF YOU ARE NOT A MEDICAL PROFESSIONAL REGISTERED WITH THE GMC OR GDC, DO NOT SUBMIT AN INQUIRY. WE ARE NOT OFFERING TRAINING TO NON-MEDICAL PERSONNEL.

 

TRAINING WILL BE PROVIDED FOLLOWING THE PURCHASE OF EUFOTON LASEMAR 1500

* We DO NOT offer training to NMC, HCPC, or GPhC professionals.